• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » U.S. Leads Global Surge in COVID-19 Clinical Trials, Report Says

U.S. Leads Global Surge in COVID-19 Clinical Trials, Report Says

February 8, 2021

The number of clinical trials focused on COVID-19 has increased 639 percent worldwide to more than 4,000 trials in January 2021, up from 549 in early April 2020. Of those new trials, 762 are being conducted in the U.S., far outpacing other countries, according to a report by marketing research firm GlobalData. China was in a distant second place with 462 trials.

GlobalData tracks all trials, including those sponsored by governments and other entities. WCG Clinical, which tracks industry-sponsored COVID-19 trials globally, says that a total of 639 trials have been announced since early 2020 and 490 of them have a documented start date.

Scotty Chung-Siu, senior analyst for GlobalData, says the largest increase in trials in the U.S. was observed between April 6 and 19, 2020, when 411 new studies were started. “That number has continued to increase every week with no regression showing,” he says, adding that “new trials are being added as companies are continuing to investigate drug candidates despite some having already been approved.”

According to the report, total COVID-19 trials worldwide hit 2,191 on June 15, 2020, 3,027 on Aug. 24, 2020, and 4,058 on Jan. 11, 2021.

COVID-19
  • Related Directories

    Veklury (remdesivir)

    Pfizer-BioNtech COVID-19 Vaccine

    Moderna COVID-19 Vaccine (mRNA-1273)

Upcoming Events

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • InputinLights-360x240.png

    Seeking Patient Input Early Helps Ensure Minority Participation in Trials

  • Oncology-360x240.png

    Global Oncology Trial Launches Drop Dramatically During Pandemic, Study Shows

  • Qualification-360x240.png

    Sites and Sponsors Streamlining Qualification Efforts with Technology, Process Revisions

  • New Algorithm Tested and Validated by CSDD Highly Predictive of Patient Burden

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing